11 IND-Enabling Safety Studies for Rare Diseases Timothy J. McGovern, Ph.D. ODE II Associate Director for Pharmacology/Toxicology September 16, 2014 1.
FDA Marks Orphan Drug Act Milestone: 30 Year Recognition January 2013.